Norepinephrine releasing agent
CATECHOLAMINERGIC TYPE OF DRUG
Norepinephrine releaser; Epinephrine releaser; Norepinephrine-epinephrine releaser; Epinephrine-norepinephrine releaser; Epinephrine-norepinephrine releasing agent; Norepinephrine-epinephrine releasing agent; Norepinephrine/epinephrine releasing agent; Epinephrine/norepinephrine releasing agent; Epinephrine/norepinephrine releaser; Norepinephrine/epinephrine releaser; Adrenaline releaser; Adrenaline releasing agent; Noradrenaline releasing agent; Noradrenaline releaser; Noradrenaline-adrenaline releaser; Noradrenaline/adrenaline releaser; Noradrenaline/adrenaline releasing agent; Noradrenaline-adrenaline releasing agent; Adrenaline-noradrenaline releasing agent; Adrenaline/noradrenaline releasing agent; Adrenaline-noradrenaline releaser; Adrenaline/noradrenaline releaser; Adrenergic releasing agent; Adrenergic releaser; Norepinephrine releasing agents
A norepinephrine releasing agent (NRA), also known as an adrenergic releasing agent, is a catecholaminergic type of drug that induces the release of norepinephrine (noradrenaline) and epinephrine (adrenaline) from the pre-synaptic neuron into the synapse. This in turn leads to increased extracellular concentrations of norepinephrine and epinephrine therefore an increase in adrenergic neurotransmission.